Cyntegrity, a renowned provider of comprehensive clinical trial risk management (CTRM) solutions, today announced the availability of its transformative MyRBQM Portal in the Microsoft Azure Marketplace, an online store offering applications and services for use on Azure. This key development empowers customers worldwide to access and deploy this innovative risk management solution in a streamlined, unified manner while taking advantage of the reliable and secure Azure cloud platform.

The MyRBQM Portal, developed by Cyntegrity, capitalizes on Microsoft Azure’s robust infrastructure and advanced security to deliver risk-based quality management capabilities for clinical research organizations. Powered by advanced data analytics and AI-supported risk management, the system facilitates efficient risk identification, assessment, and mitigation in clinical trials, improving data quality, enhancing patient safety, and optimizing clinical trial outcomes.

The seamless fusion of Cyntegrity’s MyRBQM Portal with Microsoft Azure allows biopharmaceutical organizations to harmonize this platform into their validated Azure technology stack. Real-time insights and predictive analytics furnish proactive risk management throughout the clinical trial lifecycle, equipping organizations to identify and efficiently mitigate potential risks promptly. The Portal boasts built-in functionalities to facilitate efficient risk management and mitigation, issue management, site and patient oversight, and centralized statistical monitoring. Fully ICH compliant, the system incorporates intuitive workflows that facilitate compliance with regulatory requirements and industry guidelines.

“We are excited to introduce the MyRBQM Portal in the Microsoft Azure Marketplace," said Artem Andrianov, Managing Director at Cyntegrity. "This strategic collaboration allows us to use Microsoft’s cutting-edge technologies to offer our customers a comprehensive and efficient risk-based quality management solution. Together, we are reshaping the future of clinical trials, focusing on improving patient safety and trial success rates."

Jake Zborowski, General Manager, of Microsoft Azure Platform at Microsoft Corp., said, “We’re pleased to welcome Cyntegrity’s MyRBQM Portal to the Microsoft Azure Marketplace, which gives our partners great exposure to cloud customers around the globe. Azure Marketplace offers world-class quality experiences from global trusted partners with solutions tested to work seamlessly with Azure.”

Microsoft Azure Marketplace is a curated collection of trusted applications and services optimized for Azure. It provides customers with a seamless experience to discover, try, and deploy solutions that best suit their business needs. By offering the MyRBQM Portal in the Azure Marketplace, Cyntegrity extends its reach and enables organizations worldwide to easily access and benefit from its innovative solution. Learn more about MyRBQM Portal at its page in the Azure Marketplace.

Über die Cyntegrity Germany GmbH

Cyntegrity, a leading innovator in advanced risk-based quality management solutions for CROs, sponsors, and regulators in the clinical trial space, harnesses the power of data and analytics to transform clinical trials. Cyntegrity’s solutions enable organizations across the globe to proactively identify, assess, and mitigate risks, ensuring high-quality data, patient safety, and regulatory compliance. For more information about Cyntegrity or its RBQM solutions, visit: https://cyntegrity.com

Firmenkontakt und Herausgeber der Meldung:

Cyntegrity Germany GmbH
Altenhöferallee 3
60438 Frankfurt am Main
Telefon: +49 (0) 6192-470-113-50
https://cyntegrity.com/

Ansprechpartner:
Julien Nunes Goncalves
Clinical Account Manager
E-Mail: julien.goncalves@cyntegrity.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel